Blog Layout

Investment Opportunities in HealthTech for Rural Healthcare

July 28, 2024

Rural healthcare has long been a significant challenge across the globe. In many rural areas, healthcare access is limited by geographic barriers, a shortage of healthcare professionals, and insufficient infrastructure. The consequences are often dire, with rural populations experiencing higher rates of chronic diseases, lower life expectancy, and limited access to preventive and emergency care. In this context, HealthTech offers promising solutions to bridge the gap and enhance healthcare delivery in rural settings.


The importance of HealthTech in addressing rural healthcare needs cannot be overstated. Innovations such as telemedicine, mobile health applications, and artificial intelligence (AI) have the potential to revolutionize how healthcare is provided in remote areas. These technologies can improve access, reduce costs, and enhance the quality of care. This blog aims to explore the investment opportunities in HealthTech for rural healthcare, highlighting the potential for significant returns while making a meaningful impact on underserved populations.


Rural healthcare refers to the medical services and infrastructure available to populations residing in non-urban areas. These areas are characterized by low population density, geographic isolation, and often limited access to healthcare facilities. The scope of rural healthcare includes primary care, emergency services, chronic disease management, preventive care, and health education.


Key Challenges Faced by Rural Healthcare Systems


Rural healthcare systems face several key challenges:


  1. Geographic Barriers: The vast distances between patients and healthcare facilities make access to care difficult and time-consuming.
  2. Shortage of Healthcare Professionals: Rural areas often struggle to attract and retain qualified healthcare providers, leading to a lack of specialized care.
  3. Infrastructure Deficiencies: Inadequate healthcare infrastructure, including poorly equipped clinics and hospitals, hampers the delivery of quality care.
  4. Economic Constraints: Rural populations typically have lower income levels and higher rates of uninsured individuals, limiting their ability to afford healthcare.
  5. Health Disparities: Rural residents experience higher rates of chronic conditions such as diabetes, heart disease, and mental health issues, exacerbated by limited access to care.


Examples of HealthTech Applications in Rural Healthcare


HealthTech has the potential to address many of these challenges through innovative applications:


  1. Telemedicine: Virtual consultations enable patients to connect with healthcare providers remotely, reducing the need for travel and expanding access to specialized care.
  2. Mobile Health (mHealth): Mobile applications and devices can monitor patients' health conditions, provide health education, and facilitate communication between patients and providers.
  3. AI and Machine Learning: AI can assist in diagnosing conditions, predicting outbreaks, and personalizing treatment plans, making healthcare more efficient and effective.
  4. Remote Monitoring: Wearable devices and remote monitoring tools allow continuous tracking of patients' health metrics, enabling timely interventions and reducing hospital admissions


HealthTech Solutions for Rural Healthcare


HealthTech innovations are transforming the landscape of rural healthcare. Here are some key technologies making a significant impact:


  1. Telemedicine: Telemedicine platforms enable real-time video consultations, allowing patients to receive medical advice and treatment without the need to travel. These platforms often include features like electronic health records (EHRs), appointment scheduling, and remote diagnostics.
  2. Mobile Health (mHealth): mHealth solutions include mobile apps for health tracking, patient education, and medication reminders. These apps can be particularly beneficial in managing chronic conditions and promoting healthy lifestyles.
  3. Artificial Intelligence (AI): AI algorithms can analyze large datasets to identify patterns and predict health outcomes. AI-powered diagnostic tools can assist healthcare providers in making accurate diagnoses and developing personalized treatment plans.
  4. Wearable Devices: Wearables such as smartwatches and fitness trackers can monitor vital signs, physical activity, and sleep patterns. These devices provide valuable data for healthcare providers to monitor patients' health remotely.
  5. Remote Monitoring Tools: Devices like glucose monitors, blood pressure cuffs, and pulse oximeters can transmit data to healthcare providers in real-time, enabling continuous monitoring and timely interventions.


Examples of Technologies Improving Rural Healthcare Access and Quality


  1. Telemedicine Platforms: Platforms like Teladoc and Amwell offer comprehensive telehealth services, connecting patients in rural areas with specialists in urban centers. These platforms have been instrumental in providing access to mental health services, dermatology consultations, and chronic disease management.
  2. mHealth Applications: Apps like MySugr for diabetes management and HeartCare for cardiovascular health provide patients with tools to monitor their conditions, access educational resources, and communicate with their healthcare providers.
  3. AI Diagnostic Tools: AI-powered tools like IBM Watson Health and PathAI assist in diagnosing diseases by analyzing medical images and patient data. These tools can enhance diagnostic accuracy and speed, particularly in areas with limited access to specialists.
  4. Wearable Health Devices: Devices like the Fitbit and Apple Watch monitor physical activity, heart rate, and sleep patterns. These devices can alert users to potential health issues and share data with healthcare providers for continuous monitoring.
  5. Remote Monitoring Systems: Systems like BioBeat and Tytocare provide remote monitoring solutions for chronic conditions, enabling healthcare providers to track patients' health metrics and intervene when necessary.


Case Studies of Successful HealthTech Solutions


  1. Project ECHO: Project ECHO (Extension for Community Healthcare Outcomes) uses telemedicine to connect rural healthcare providers with specialists at academic medical centers. This model has been successful in managing chronic diseases like hepatitis C and diabetes, improving patient outcomes through specialist support and education.
  2. Babylon Health: Babylon Health offers an AI-powered telehealth platform that provides remote consultations, health assessments, and personalized health plans. The platform has been effective in rural areas of Africa and Asia, where access to healthcare is limited.
  3. Ping An Good Doctor: This Chinese telemedicine platform offers online consultations, health management services, and medication delivery. It has been particularly successful in reaching rural populations, providing access to healthcare services that were previously unavailable.


Benefits of HealthTech in Rural Healthcare


One of the most significant benefits of HealthTech in rural healthcare is improved access to medical services. Telemedicine, for instance, allows patients to consult with doctors and specialists without the need to travel long distances. This is particularly important for rural populations who may face transportation challenges and limited availability of local healthcare providers. By using telehealth platforms, patients can receive timely medical advice, diagnosis, and treatment from the comfort of their homes

.

Enhanced Patient Outcomes and Quality of Care

HealthTech innovations have the potential to enhance patient outcomes and the overall quality of care in rural areas. Remote monitoring tools and wearable devices enable continuous tracking of patients' health metrics, allowing for early detection of potential issues and timely interventions. AI-powered diagnostic tools improve the accuracy and speed of diagnoses, ensuring that patients receive appropriate treatments promptly. Additionally, mHealth applications provide patients with valuable information and resources to manage their conditions effectively.


Cost Savings and Resource Optimization

Implementing HealthTech solutions in rural healthcare can lead to significant cost savings and resource optimization. Telemedicine reduces the need for physical infrastructure and travel expenses, while remote monitoring tools decrease the frequency of hospital visits and admissions. AI-driven technologies streamline administrative tasks and enhance clinical workflows, allowing healthcare providers to focus on patient care. These efficiencies result in reduced healthcare costs and better allocation of resources.


Challenges and Risks


While HealthTech offers numerous benefits, there are also challenges and risks associated with its adoption in rural healthcare settings. Some of these challenges include:


  1. Technology Infrastructure: Rural areas may lack the necessary infrastructure, such as high-speed internet and reliable electricity, to support HealthTech solutions.
  2. Digital Literacy: Patients and healthcare providers in rural areas may have limited experience with digital technologies, making it challenging to implement and use HealthTech effectively.
  3. Data Security and Privacy: The use of digital health platforms raises concerns about data security and patient privacy. Ensuring that patient information is protected from breaches and unauthorized access is crucial.
  4. Regulatory and Compliance Hurdles: HealthTech solutions must comply with various regulations and standards, which can be complex and time-consuming to navigate.


Strategies for Overcoming These Challenges


To address these challenges, several strategies can be implemented:


  1. Infrastructure Development: Investing in the development of technology infrastructure in rural areas is essential. This includes improving internet connectivity and ensuring reliable access to electricity.
  2. Training and Education: Providing training and education for both patients and healthcare providers can help increase digital literacy and promote the effective use of HealthTech solutions.
  3. Data Security Measures: Implementing robust data security measures, such as encryption and secure authentication, can help protect patient information and ensure compliance with regulations.
  4. Regulatory Support: Advocating for supportive regulatory frameworks and policies can facilitate the adoption of HealthTech solutions in rural healthcare.


Investment Strategies in Rural Healthcare HealthTech


Investors interested in HealthTech for rural healthcare should focus on identifying companies and technologies with the potential to address the unique challenges of rural settings. Key areas to consider include telemedicine platforms, remote monitoring tools, AI diagnostic solutions, and mHealth applications. Companies that have demonstrated success in urban and suburban markets may also have the potential to expand into rural areas with the right support and adaptation.


When evaluating investment opportunities in HealthTech for rural healthcare, several factors should be considered:


  1. Market Demand: Assess the demand for HealthTech solutions in rural areas, considering factors such as population size, healthcare access, and prevalent health conditions.
  2. Technology Adaptability: Evaluate the adaptability of the technology to rural settings, including infrastructure requirements and ease of use for patients and healthcare providers.
  3. Regulatory Compliance: Ensure that the technology complies with relevant regulations and standards, and assess the company's ability to navigate regulatory hurdles.
  4. Scalability: Consider the scalability of the technology and its potential to be implemented in multiple rural locations.


Long-Term vs. Short-Term Investment Strategies


Investors should also consider their investment horizon when entering the HealthTech market for rural healthcare:


  1. Long-Term Investments: Long-term investments may involve supporting early-stage startups and emerging technologies with significant growth potential. These investments require patience and a willingness to support the company's development over several years.
  2. Short-Term Investments: Short-term investments may focus on companies that are already established and have a proven track record of success. These investments can provide quicker returns but may offer less growth potential compared to early-stage ventures.


Notable Labs: Driving HealthTech Innovations for Rural Healthcare


Notable Labs is at the forefront of leveraging precision medicine to address the unique challenges of rural healthcare. By integrating advanced genetic and molecular analyses into standard healthcare practices, Notable Labs collaborates with insurers and healthcare providers to pioneer innovative HealthTech solutions that are accessible and affordable for rural populations. Their commitment to evidence-based practices and robust clinical data supports the development of reimbursement policies that recognize the value and cost-effectiveness of precision medicine. As a leader in the field, Notable Labs exemplifies the potential for HealthTech to transform rural healthcare, improving patient outcomes and setting a new standard for integrating cutting-edge medical advancements into everyday healthcare. Their work paves the way for a future where personalized healthcare is accessible to all, ensuring that each patient, regardless of location, receives the most effective and individualized treatment possible.


Future Trends and Innovations


Several emerging trends and future directions are shaping the HealthTech landscape for rural healthcare:


  1. Integration of AI and Machine Learning: AI and machine learning are being increasingly integrated into HealthTech solutions, enhancing diagnostic accuracy, predicting health outcomes, and personalizing treatment plans.
  2. Expansion of Telehealth Services: Telehealth services are expanding beyond primary care to include specialized services such as mental health, dermatology, and chronic disease management.
  3. Development of Wearable Health Devices: Wearable health devices are becoming more sophisticated, with capabilities to monitor a wide range of health metrics and provide real-time data to healthcare providers.
  4. Blockchain for Health Data Security: Blockchain technology is being explored for its potential to enhance health data security and interoperability, addressing concerns about data privacy and sharing.


The Impact of Technological Advancements on Rural Healthcare


Technological advancements are transforming rural healthcare by making it more accessible, efficient, and patient-centered. Innovations such as AI, telemedicine, and wearable devices are breaking down geographic barriers, enabling continuous health monitoring, and facilitating early intervention. These advancements are not only improving health outcomes for rural populations but also making healthcare more cost-effective and sustainable.


Predictions for the Next Decade in Rural Healthcare HealthTech


Over the next decade, several key developments are expected in rural healthcare HealthTech:


  1. Widespread Adoption of Telemedicine: Telemedicine is expected to become a standard component of rural healthcare, providing patients with access to a wide range of medical services without the need for travel.
  2. Increased Use of AI in Diagnostics and Treatment: AI will play a critical role in diagnosing and treating health conditions, providing healthcare providers with powerful tools to enhance patient care.
  3. Growth of Remote Monitoring and Wearable Devices: Remote monitoring and wearable devices will become more prevalent, enabling continuous health monitoring and proactive management of chronic conditions.
  4. Advancements in Mobile Health Applications: mHealth applications will continue to evolve, offering more comprehensive and personalized health management solutions for rural populations.


Conclusion


In conclusion, investing in HealthTech solutions for rural healthcare presents a unique opportunity to address the significant challenges faced by rural populations while achieving substantial returns on investment. HealthTech innovations such as telemedicine, mobile health, AI, and wearable devices have the potential to revolutionize rural healthcare by improving access, enhancing patient outcomes, and reducing costs. However, investors must carefully consider the unique challenges and risks associated with rural healthcare and adopt strategies that support long-term growth and sustainability. The future of rural healthcare HealthTech is promising, with emerging trends and technological advancements poised to transform the healthcare landscape. By supporting and investing in innovative HealthTech solutions, stakeholders can play a crucial role in improving the health and well-being of rural communities, ensuring that all individuals have access to high-quality healthcare regardless of their geographic location.

A nurse is holding a bottle of pills in her hand.

HealthTech Innovations in Chronic Disease Management

July 29, 2024
Discover how HealthTech innovations are transforming chronic disease management. This blog highlights the latest technologies like remote monitoring, AI, and mobile apps, which improve patient care, outcomes, and reduce costs. Explore real-world examples and see how personalized and preventive approaches enhance quality of life for millions.
A female doctor wearing a white coat with a stethoscope around her neck.

Notable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study

By Daniel Ferry • July 29, 2024
Notable Labs is a clinical-stage precision oncology company developing new cancer therapies identified by its Predictive Medicine Platform (PMP), today announced progress for the Phase 2 volasertib program following receipt of “Clearance to Proceed” from the FDA and agreement on the dosing plan for its Phase 2 clinical trial. With trial start-up activities launched in the first quarter of this year, Notable intends to initiate enrollment in the Phase 2 study for PMP-enabled development of volasertib for relapsed refractory (R/R) acute myeloid leukemia (AML) in the coming months.
A man in a lab coat and mask is holding a box of test tubes.

Notable Labs: Revolutionizing Pediatric Leukemia Treatment

By Syeda Abeer Iqbal • July 29, 2024
Notable Labs is transforming pediatric leukemia treatment with its Predictive Precision Medicines Platform (PPMP), which boasts a 97% predictive precision. This platform rapidly identifies the most effective treatments for individual patients, significantly reducing the time and cost of cancer therapy. Notable Labs focuses on personalized medicine, combining high-throughput screening and machine learning to predict patient responses and tailor treatments accordingly. Their innovative approach has shown promising results in clinical validation studies, offering new hope for improving outcomes in pediatric leukemia.
A man in a lab coat is pushing a cart down a hallway.

Notable Labs' Innovative Approach to Cancer Treatment

By Scott Smith • July 29, 2024
Notable Labs is revolutionizing cancer treatment with its innovative approach to combination therapy, which targets multiple cancer pathways simultaneously. Their Predictive Precision Medicine Platform (PPMP) leverages advanced data analysis and machine learning to identify the most effective drug combinations for individual patients. By using high-throughput screening and bio-simulation, Notable Labs accelerates drug development, reduces costs, and improves clinical trial success rates. This approach promises significant improvements in patient outcomes, particularly for pediatric leukemia, by providing personalized, effective treatments and minimizing side effects.
A woman is laying in a dental chair in a dark room looking up.

Notable Labs Revolutionizing Precision Medicine

By Ayushi Hisaria • July 29, 2024
Notable Labs' cutting-edge diagnostic technology, boasting a 95% prediction accuracy per a Stanford study, is set to revolutionize pediatric leukemia treatment by identifying the most effective therapies. Their mission centers on advancing precision diagnostics to enhance therapy efficacy for young patients. Utilizing high-throughput screening and machine learning, Notable's platform offers tailored treatment plans, significantly improving outcomes for rare and aggressive forms of leukemia. This approach holds promise for personalized medicine, ensuring each child receives optimal, life-saving care.
A woman wearing headphones and a red sweater is stretching her arms in the woods.

How Notable Labs is Revolutionizing Cancer Treatment

By Kathleen Mackay • July 29, 2024
Notable Labs is transforming cancer treatment with its innovative combination therapy approach. By leveraging its Predictive Precision Medicine Platform (PPMP), Notable identifies optimal drug combinations tailored to individual patients. This methodology aims to reduce the development of resistant cancer cells and allows each drug to be used at its best dosage without intolerable side effects. The platform has shown impressive predictive accuracy in clinical trials, particularly for pediatric leukemia. Notable's commitment to precision medicine offers new hope for patients with high unmet medical needs, driving better treatment outcomes and enhancing quality of life.
Two little girls are sitting at a table painting with brushes.

Innovative Diagnostics for Pediatric Leukemia: The Notable Labs Advantage

By Fabian Goguta • July 29, 2024
Notable Labs leverages predictive precision medicine to revolutionize cancer treatment, particularly pediatric leukemia. Their Predictive Medicine Platform (PMP) uses advanced technologies like flow cytometry and machine learning to analyze patient-specific cancer cell responses, offering highly accurate predictions for effective treatments. Clinical validation studies have shown a 97% precision in predicting responders. Collaborations with renowned institutions like Texas Children’s Hospital and UCSF further highlight Notable's commitment to improving pediatric oncology outcomes, making personalized, rapid, and effective cancer treatments a reality.
A woman and a little girl are sitting on the floor.

Precision Medicine in Pediatric Leukemia

By Divya Narasimhan, MSc • July 29, 2024
Precision medicine is revolutionizing pediatric leukemia treatment by offering tailored therapies based on individual genetic profiles. Notable Labs’ predictive precision medicine platform, driven by machine learning, is at the forefront of this transformation. With a 95% accuracy rate, this technology identifies the most effective treatments for rare and aggressive leukemia subtypes, such as pAML and JMML, ensuring better outcomes. This blog explores the advanced technological foundations, life-saving impact, and promising future of Notable Labs' approach in personalized cancer care for children.
A person is holding a baby 's hand on a bed.

Precision Medicine in Childhood Leukemia

By Dr. David Letsa • July 29, 2024
Notable Labs, founded by Matthew De Silva, emerged from his personal quest to find better treatments for glioblastoma after his father's diagnosis. Partnering with Dr. Thomas Bock, De Silva's vision turned into a biotech startup revolutionizing cancer treatment through its Predictive Precision Medicine Platform (PPMP). The company's leadership team includes industry veterans like Dr. Joseph Wagner, Dr. Glenn Michelson, and Scott McPherson. Headquartered in Foster City, California, Notable Labs collaborates with top hospitals and leverages cutting-edge drug screening technology to deliver personalized cancer therapies, significantly improving patient outcomes.
A microscope is sitting on top of a table in a laboratory.

The Promise of Combination Therapy

By Dr. Anjaney Kothari • July 29, 2024
Given the complexity of the biological mechanisms that underlie cancer, it is prudent to identify and target more than one Achilles’ heel to attack this multifactorial disease. This can be achieved by employing combination therapy, an approach to cancer treatment that combines multiple therapeutic agents to improve patient outcomes. Notable Labs is at the forefront of revolutionary advancements in combination therapy, one noteworthy example being its long-standing collaboration with Syros Pharmaceuticals. For Syros, Notable developed a highly efficient predictive biological test to screen patients for the clinical trial of a combination therapy against non-acute promyelocytic leukemia (APL) acute myeloid leukemia (AML). Notable Labs’ innovative approach to combination therapy holds immense promise for significantly improving cancer treatment outcomes despite current limitations in commercial pursuit. This blog dives into the science behind the promise of combination therapy, how Notable is contributing toward the evolution of this technology, and why the company’s Board of Directors is excellently positioned to advance this field in the future. Notable Labs' investigation into combination therapy against cancer is backed by decades of scientific research. Combination therapy holds immense promise in the fight against cancer because of its ability to additively or synergistically target two or more cancer pathways. Due to its multi-target approach, combination therapy is also an effective strategy to overcome anti-cancer drug resistance. By collaborating with Syros in 2017, Notable Labs contributed to the phase II clinical trial of a therapy combining the drugs tamibarotene and azacitidine against non-APL AML. For this multi-arm monotherapy and combination therapy trial, Notable developed a blood-based biomarker test to help predict patient response to treatment. Specifically, Notable was involved in conducting ex vivo experiments on peripheral blood mononuclear cells (PBMCs) isolated from the blood samples of non-APL AML patients. Harnessing the power of high-throughput flow cytometry, these experiments revealed that a 72-hour ex vivo exposure of PBMCs to tamibarotene upregulates various markers of myeloid cell differentiation, including the RARα pathway target CD38. Importantly, treatments that can promote myeloid cell differentiation are known to be effective against some subtypes of AML. Therefore, by testing a patient’s blood sample using Notable’s ex vivo approach, it is possible to predict whether the patient is likely to respond well to tamibarotene in monotherapy and combination therapy. Indeed, Notable’s ex vivo assay became one of the strategies Syros adopted when screening patients for enrolment in the phase II clinical trial of tamibarotene (alone as well as in combination with azacitidine). Market Challenges Currently, cancer treatment – and thus, the oncology market as a whole – is faced with a three-pronged challenge. There are millions of non-responders who are not benefiting from chemotherapeutic drugs, thousands of compelling drugs that need to be shelved because of perceived non-response, and hundreds of promising candidate drugs that are struggling to navigate the drug development pipeline. Notable Labs is committed to resolving these challenges through its successfully tested predictive precision medicine pipeline, a significant application of which was demonstrated during the Syros clinical trial.  Notable Labs’ commitment is also one of the reasons why it has decided not to commercialize the combination therapy technology immediately. Notable wants to focus on refining the technology further, expanding its applications, and ensuring that it integrates seamlessly into existing healthcare systems. The company aims to develop more sophisticated prediction models and address regulatory and logistical challenges. This approach will help make Notable's technology accessible to a broader patient population, maximizing the life-saving potential of predictive diagnostics as well as combination therapy. Broader Applications The high-throughput nature of Notable’s ex vivo flow-cytometry-based predictive precision medicine pipeline has helped identify many powerful drug combinations to treat other cancers such as juvenile myelomonocytic leukemia. This pipeline also has great potential for identifying effective drug combinations and guiding patient enrolment in clinical trials of combination therapies for other cancers, including solid tumors. In the case of solid tumors, the Notable pipeline’s blood samples for ex vivo testing could be replaced by biopsy samples, circulating tumor cells, pleural effusion, or ascites, among other sampling options. Founding Story Notable’s CEO, Dr. Thomas Bock (MD, MBA), has ensured that the company is well-positioned to transform combination therapy for cancer. For decades, our CEO has worked on multiple dimensions of oncology, including precision medicine, prevention of inherited cancers, and cancer vaccines. At Notable, Dr. Bock combines his medical and business training to accomplish the company’s mission of dramatically improving patient outcomes and the success, speed, and cost of developing new medicines. Strength of the Board of Directors Notable’s esteemed Board of Directors boasts of more than 150 years of combined professional experience in premier life science companies. Our board members excel in medicine (Dr. Bock), pharmacology (Mr. Tuomo Pätsi), business (Dr. Bock), finance (Mr. Michael Rice, Mr. Peter Feinberg, Mr. Thomas Graney), media communications (Ms. Michele Galen), and law (Mr. Thomas Dubin), fostering a vibrant and eclectic environment for Notable to thrive. This diverse team of bona fide giants from the pharmaceutical and biotechnology sectors is set to efficiently guide Notable Labs on its path to success in combination therapy and beyond. Conclusion Combination therapy for cancer, aided by predictive methods, could significantly improve patient outcomes while also broadening the population of patients who can benefit from a given drug combination. Leading the charge in this direction, Notable Labs’ predictive precision medicine pipeline boasts of massive potential to not only identify effective drug combinations for combination therapy, but also guide patient enrolment in clinical trials through predictive screening. Moving ahead, Notable’s technology is set to transform the treatment of multiple types of cancer by ensuring positive patient outcomes of personalized combination therapies in shorter times and at lower costs. Additional Data Points AML statistics (American Cancer Society): estimated 20,800 new diagnoses and 11, 220 deaths in the US in 2024. Success stories and collaborations in the field of combination therapy: Notable’s collaboration with Syros to develop a predictive test for patient response to monotherapy and combination therapy. Potential impact on cancer treatment outcomes: Combination therapy, aided by predictive methods, has the potential to enhance patient outcome while also broadening the population of patients who can benefit from a given combination of drugs. Future directions for research and development: AML treatment strategies must pivot towards personalized/precision medicine because of overwhelming heterogeneity of the disease. References Combination therapy in combating cancer . (2017). Oncotarget Notable’s collaboration with Syros . (2017). Notable Labs + Syros Differentiation therapy for myeloid malignancies: beyond cytotoxicity . (2021). Blood Cancer Journal New strategies to treat AML: novel insights into AML survival pathways and combination therapies . (2021). Leukemia Precision oncology using ex vivo technology: a step towards individualised cancer care? . (2022). Expert Reviews in Molecular Medicine Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML . (2023). Blood Advances Notable Labs’ JMML data . (2023). Notable Labs Key statistics for acute myeloid leukemia (AML) . (2024). American Cancer Society About the Author Dr. Anjaney Kothari is a scientific writer and researcher with a decade of experience in biomedical research. He completed his Ph.D. in Biomedical Engineering from Virginia Tech (USA) in 2019, developing and characterizing holistic in vitro and ex vivo models of hepatic and gastrointestinal toxicity. He has since been working as a freelance writer and researcher for companies operating in diverse niches, including biotechnology and biopharmaceuticals. Disclaimer The content of these blogs reflects the research and opinions of the individual authors and does not necessarily represent the views or positions of Notable Labs or its affiliates. The information provided is for educational and informational purposes only and should not be construed as medical, legal, or financial advice. Notable Labs makes no representations as to the accuracy, completeness, or validity of any information in these blogs and will not be liable for any errors, omissions, or any losses, injuries, or damages arising from their use. These blogs may reference third-party research, studies, or resources. Notable Labs does not endorse or assume responsibility for the content or practices of these third parties. Any reliance on the information provided is at the reader's own risk. For biotechnology and pharmaceutical content, note that ongoing research and clinical trials may change the context and results discussed. Always refer to the latest research and guidelines from reputable sources.
More Posts
Share by: